drugset
drugset / Trial / NCT05707897

A Food Effect Study of TS-142 in Healthy Subjects

NCT05707897 ↗

Phase 1 Completed 12 enrolled Taisho Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This is a study to assess the food effect of TS-142 preliminary market formulation tablet in healthy subjects

Timeline

Start
2023-02-15
Primary completion
2023-03-20
Completion
2023-03-20

Drugs

EvaluationDrugModalityDoseRoute
Subject TS-142 Small molecule 10 mg Oral

Indications

No indication recorded.